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Case vignette 
A clinical entry, after specialist referral of a patient who experienced a 
postoperative troponin elevation, reads as follows: ‘Thank you for the 
referral. Reason for referral: postoperative troponin elevation following 
total hip replacement. According to the history, the patient was 
asymptomatic and comfortable in the ward. No ischaemic symptoms 
or electrocardiogram [ECG] changes noted. Vital signs were within 
normal limits. Assessment: isolated troponin elevation, expected in this 
patient population and not clinically significant. Recommendation: 
review patient for symptoms, no specific therapy required.’
After an uneventful hospital stay, the patient was discharged on the 
4th postoperative day, but died 5 days later at home.
The global surgical volume has increased to >300 million proce­
dures per annum.[1] Cardiovascular complications contribute to 
one­third of major perioperative morbidity and mortality, with 
perioperative myocardial infarction and myocardial injury after 
non­cardiac surgery (MINS) accounting for 39% of all deaths within 
30 days of non­cardiac surgery.[2] These deaths are distributed 
equally between patients who sustain a postoperative myocardial 
infarction and MINS.[2] The burden of perioperative cardiovascular 
complications, therefore, has a major public health importance. 
The paucity of clinicians with an appreciation of the importance of 
perioperative myocardial injuries and the associated prognosis, and 
the knowledge necessary to manage this public healthcare burden, 
needs to be addressed.[3] 
Methods
A literature search on MINS in the perioperative period was conducted 
using MEDLINE and the following search terms: ‘myocardial injury’, 
‘noncardiac surgery’, ‘mortality’, ‘perioperative complications’, 
‘treatment’, ‘prevention’ and ‘guidelines’. Additional reports were 
obtained by reviewing reference lists from the literature. Studies 
involving large cohorts with clear inclusion criteria and outcome data 
were reviewed. Reviews and smaller studies with local significance 
were also included.
MINS
MINS occurs when myocardial ischaemia­related cellular damage 
occurs in the perioperative period. It has been defined as an elevated 
cardiac troponin T (cTnT) level that was considered as resulting 
from myocardial ischaemia without evidence of a non­ischaemic 
cause of cTnT elevation (Table 1).[4] The pathophysiology of MINS 
in surgical patients differs from that of myocardial infarction in 
medical (non­surgical) patients.[5] Surgical patients are exposed 
to a unique environment that includes sympathetic activation, 
bleeding, anaemia, pain, hypotension and hypercoagulability during 
the perioperative period. Another distinctive clinical feature of MINS 
is that it most commonly presents within the first 3 postoperative 
days, strengthening its association with the early postoperative 
pathophysiological environment, in contrast to postoperative 
atherosclerotic plaque rupture that tends to occur more randomly 
during the weeks after surgery, and more closely resembles a 
traditional medical (non­surgical) myocardial infarction.[5] 
Incidence of MINS
International data estimate that >100 million adults ≥45 years of age 
undergo non­cardiac surgery per annum.[2] In the recent Vascular 
Events In Non­cardiac Surgery Patients Cohort Evaluation (VISION) 
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study non­cardiac surgical patients were studied for perioperative 
complications.[6] More than 40 000 patients were enrolled, of 
whom 7% experienced MINS.[4,7] MINS is therefore a common 
perioperative complication, especially when one considers the non­
selec tive nature of the VISION study’s inclusion criteria: ≥45 years 
of age and the need to spend a night in hospital following surgery, 
thereby providing a representative sample of perioperative outcomes 
in unselected surgical patients. Therefore, about 1 in 14 in­hospital 
patients ≥45 years old, who undergo non­cardiac surgery, will 
experience MINS as a perioperative complication. Factors that 
increase the risk for experiencing MINS occur commonly in 
our surgical population. These include increasing age, patients 
with known cardiovascular disease or known risk factors for 
cardiovascular disease, and operations associated with an elevated 
risk (typically intermediate and major surgical severity, and all non­
elective surgery) (Table 2).[4] 
Clinical presentation of MINS in the postoperative 
period
To diagnose medical (non­surgical) myocardial infarction, the 
diagnostic criteria require documented elevated cardiac biomarkers 
and features of ischaemia (clinical, electrocardiographic or imaging).[8] 
Current studies employ cTnT, as it is universally standardised.[9] In 
contrast to medical myocardial infarction, clinical features of ischaemia 
are notoriously absent in surgical patients. Therefore, the diagnosis of 
MINS hinges on perioperative troponin elevation, and the exclusion 
of known non­ischaemic causes of perioperative troponin elevation, 
e.g. sepsis and pulmonary embolism.[4] More than 93% of patients 
who experienced MINS, did not fulfil the diagnostic criteria for the 
universal definition of myocardial infarction; only 7% presented with 
ischaemic symptoms and 15% had nonspecific ECG changes.[4,7] 
The majority of troponin elevations occur within 48 hours of 
surgery, and the patient’s prognosis is positively correlated with 
the peak troponin level.[4,7] Studies of the high­sensitivity cTnT 
(hs­cTnT) test found that a small absolute increase in hs­cTnT from 
the preoperative to the postoperative period has prognostic use 
(Table 1).[7] Furthermore, observational data have shown that ~50% 
of patients demonstrate an early 24­hour postoperative window, 
where the troponin levels remain low before a subsequent rise in 
these levels, highlighting the need for serial troponin surveillance in 
the postoperative period.[10] As most of the prognostically significant 
troponin elevations occur asymptomatically, it is inappropriate to 
depend on ECG changes or ischaemic symptomatology to alert 
a clinician to MINS, as this will result in the majority (>80%) of 
diagnoses being missed.[4] 
Cardiac troponin T thresholds should be considered 
according to clinical context 
The diagnostic troponin thresholds for MINS differ from those used 
to diagnose medical patients with myocardial infarction.[4,7,8] Before 
cardiac biomarkers are used in clinical practice, their diagnostic 
thresholds need to be determined by investigating specific reference 
populations.[8] The clinical environment of surgical and medical 
patients differs, which influences the sensitivity and specificity of 
these tests for specific outcomes and therefore requires population­
specific investigation.[9] The literature investigating different troponin 
assays in perioperative patients has provided assay­specific troponin 
levels that are of prognostic relevance in the surgical patient (i.e. 
independently associated with 30­day mortality),[4,7] but may not be 
typically associated with an adverse prognosis in the non­surgical 
patient (Table 1).
Prognosis of surgical patients with MINS
MINS has a 30­day mortality of 10%.[4] One in 10 patients with MINS 
dies, and 1 in 5 patients suffers a major cardiovascular complication 
(congestive cardiac failure, non­fatal cardiac arrest and stroke) within 
30 days of surgery.[4] Various investigators have reported similar 
outcomes, as demonstrated by two meta­analyses independently 
associating postoperative troponin elevation with long­ and short­
term mortality.[3] A recent study found that the incidence of MINS in 
a South African (SA) patient population was comparable with those 
of large international cohorts.[11] The 1 500 SA patients included in 
the VISION cohort also suggested findings that could be compared 
with those of other international cohorts, and showed no evidence of 
differences between clusters.[6,7] It is therefore reasonable to assume 
that the SA patient population has a similar risk for MINS and 
outcomes after MINS to that in the literature. 
Patients who develop MINS postoperatively, have prognostic risk 
factors independently associated with 30­day mortality (Table 3).[4] 
A point system allows for prediction of the risk of 30­day mor tality: 
Table 1. MINS diagnostic criteria and hs-cTnT thresholds 
independently associated with 30-day mortality[7]
MINS diagnostic criteria (only one required)
Any peak hs­cTnT ≥65 ng/L
 An absolute increase in hs­cTnT of 5 ng/L, with peak cTnT 20 ­ 64 ng/L
hs-cTnT thresholds associated with  
30-day mortality
hs-cTnT, ng/L
Adjusted hazard 
ratio (95% CI)* 30-day mortality, % 
14 ­ <20 9.1 (3.8 ­ 22.1) 1.1
20 ­ <65 23.6 (10.3 ­ 54.1) 3.0
65 ­ <1 000 70.3 (30.6 ­ 161.7) 9.1
≥1 000 227.0 (87.4 ­ 589.9) 29.6
MINS = myocardial injury after non­cardiac surgery; hs­cTnT = high­sensitivity cardiac 
troponin T; CI = confidence interval. 
*All p<0.001.
Table 2. Perioperative risk factors for the development of 
MINS[4]
Risk factor
Increasing age
Current atrial fibrillation
Diabetes
Hypertension
Congestive heart failure
Coronary artery disease
Peripheral vascular disease
Stroke
Decreasing renal function
Urgent or emergency surgery
MINS = myocardial injury after non­cardiac surgery.
Table 3. Independent predictors of 30-day mortality in 
patients who experience MINS[4]
Independent predictors
Adjusted odds ratio 
(95% CI)*
Age ≥75 years 2.06 (1.33 ­ 3.37)
ST elevation or new LBBB 3.96 (1.54 ­ 9.14)
Anterior ischaemic changes on ECG 2.33 (1.42 ­ 3.70)
MINS = myocardial injury after non­cardiac surgery; LBBB = left bundle branch block; 
ECG = electrocardiogram; CI = confidence interval. 
*All p<0.01.
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0 points (5%), 1 point (10%), 2 points (20%), 
3 points (30%) and 4 points (50%).[4] The cTnT 
diagnostic thresholds required for MINS, 
along with the 30­day prognostic impact, 
are shown in Table 1. The prognostically sig­
nificant impact of MINS in the perioperative 
period is thus clear and therefore demands 
that clinicians understand the clinical entity 
of MINS and its associated diagnostic crite­
ria, prognosis, prognostic markers and the 
need for active therapeutic intervention. The 
consultation example shown in the introduc­
tion of this article can therefore no longer be 
accepted.
Proposed management of MINS
The most recently published perioperative 
cardiovascular guidelines propose postoperative 
troponin surveillance for patients who have a 
>5% risk of a perioperative major adverse 
cardiovascular event. The following criteria 
apply: (i) any patient ≥65 years of age; 
(ii) patients between 45 and 64 years of age 
with a revised cardiac risk index (RCRI) 
of ≥1; or (iii) any patient with an elevated 
preoperative natriuretic peptide (including 
brain natriuretic peptide or N­terminal 
probrain natriuretic pep tide).[12] The recent 
Canadian guidelines on cTnT surveillance 
and RCRI score are summarised in Table 4. 
As complications are common in the first 
week after MINS, we would advocate early 
intervention.[13] Evidence from randomised 
controlled trials is lacking, but we expect 
this to change over the next few years.[3] 
The Management of Myocardial Injury 
After Noncardiac Surgery Trial (MANAGE) 
(clinicaltrials.gov/ct2/show/NCT01661101) 
results are currently in press, but initial 
reports indicate improved primary end­
points. MANAGE evaluated the impact of 
anticoagulation on perioperative vascular 
complications after MINS.  The final results 
will provide more insight into therapeutic 
options. 
Current observational data suggest 
that simple therapeutic measures could 
improve outcomes once MINS occurs. The 
literature supports the use of postoperative 
aspirin administration and statin therapy 
to reduce 30­day mortality after MINS.[14] 
Furthermore, intensification of therapy 
(defined as introducing or increasing 
any of the following cardiovascular drug 
groups: antiplatelet agents, beta­blockers, 
statins or angiotensin converting enzyme 
inhibitors) during the postoperative period 
has been shown to be associated with an 
improved 1­year survival.[15] However, 
deciding on a specific therapy should be 
part of a multidisciplinary approach. The 
potential benefits of therapies should be 
weighed against potential risks on an 
individual basis. After initiation of treatment 
intensification, surveillance for additional 
prognostic information should continue 
(Table 3).[4] Increased postoperative moni­
toring (i.e. continuous invasive haemodynamic 
monitoring and a high­care facility) and 
optimised myocardial oxygen balance (i.e. 
haemodynamic support, correction of 
anaemia and electrolyte disturbances) could 
be of additional benefit, but is currently 
only supported by recommendations.[13] 
A pharmacoeconomic study showed that 
troponin surveillance in the SA context 
should be cost­effective for all patients 
≥45 years of age who undergo non­cardiac 
surgery, but only when combined with active 
intervention once MINS is diagnosed.[16] 
An adapted proposed algorithm for MINS 
management is depicted in Fig. 1. 
Conclusion
MINS commonly occurs in non­cardiac 
surgical patients ≥ 45 years of age. Ten per­
cent of patients who experience MINS die 
within 30 days of surgery. MINS can be easily 
diagnosed if routine, postoperative hs­cTnT 
surveillance is conducted, as recommended 
by current international guidelines, and it is 
likely to be cost­effective in SA. Once MINS 
is diagnosed, institution of simple therapies 
may improve outcome. Large studies are 
expected to provide more therapeutic insight 
in the near future. Screening and treatment 
of MINS need to be incorporated into 
routine postoperative surgical management.
Table 4. Postoperative troponin surveillance recommendations from the Canadian 
Cardiovascular Society Guidelines[12,17]
Daily postoperative cTnT surveillance for 48 ­ 72 hours if baseline risk >5% for 
cardiovascular death or non­fatal myocardial infarction at 30 days after surgery, including:[12]
Elevated preoperative NT­proBNP or BNP measurement
RCRI score ≥1*
Age 45 ­ 64 years, with significant cardiovascular disease*
Age ≥65 years*
RCRI[17]
 High­risk­type surgery (intraperitoneal, intrathoracic or supra­inguinal vascular)
Ischaemic heart disease
History of congestive heart failure
History of cerebrovascular disease
Insulin therapy for diabetes
Preoperative serum creatinine >2.0 mg/dL (177 µmol/L)
RCRI = revised cardiac risk index; NT­proBNP = N­terminal probrain natriuretic peptide; BNP = brain natriuretic peptide; 
cTnT = cardiac troponin T; CI = confidence interval. 
*If preoperative NT­proBNP or BNP not available.
Oxygen
Optimise haemoglobin
Aspirin ± clopidogrel
Statin
ACE inhibitor or ARB
Anticoagulation
± morphine, ± nitroglycerine
Haemodynamically stable
Beta-blockade
Haemodynamically unstable
Manage hypotension and dysrhythmias
Add beta-blocker when stable
Consider coronary angiogram if:
(i) ST elevation
(ii) ST depression with recurrent symptoms and no contraindication to heparin
Fig. 1. Proposed algorithm for the management of patients with MINS. (Adapted from Biccard.[18] 
MINS = myocardial injury after non-cardiac surgery; ACE inhibitor = angiotensin converting enzyme 
inhibitor; ARB = angiotensin receptor blocker.)
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